DEREK JANTZ - 12 May 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ Derek Jantz
Issuer symbol
DTIL
Transactions as of
12 May 2021
Net transactions value
-$171,162
Form type
4
Filing time
14 May 2021, 16:47:07 UTC
Next filing
18 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise $861 +21,514 +0.54% $0.0400* 4,038,273 12 May 2021 Direct
transaction DTIL Common Stock Sale $84,375 -9,676 -0.24% $8.72 4,028,597 12 May 2021 Direct F1
transaction DTIL Common Stock Options Exercise $861 +21,514 +0.53% $0.0400* 4,050,111 13 May 2021 Direct
transaction DTIL Common Stock Sale $88,508 -9,673 -0.24% $9.15 4,040,438 13 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Employee Stock Option (Right to Buy) Options Exercise $0 -21,514 -33% $0.000000 43,028 12 May 2021 Common Stock 21,514 $0.0400 Direct F2
transaction DTIL Employee Stock Option (Right to Buy) Options Exercise $0 -21,514 -50% $0.000000 21,514 13 May 2021 Common Stock 21,514 $0.0400 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
F2 The option is fully vested and exercisable.